lobbying_activities: 3342371

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3342371	5fc241fd-6067-40d0-96ba-eb596c1bed24	1T	THORN RUN PARTNERS	400534596	PROFESSIONAL COMPOUNDING CENTERS OF AMERICA	2025	first_quarter	PHA	Issues related to the Drug Quality and Security Act, Compounding Pharmacy, Reimbursement, and Patient Access, animal compounding, and H.R.167 - Patient Access to Urgent-Use Pharmacy Compounding Act of 2023. H.R.3810 - Drug Origin Transparency Act of 2023.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	1	2025-04-17T16:01:28-04:00